(Q34196148)

31 July 2017

1 reference

title

Perioperative management and reversal of antithrombotic therapy (English)

1 reference

31 July 2017

Jacobs LG

1

1 reference

31 July 2017

Nusbaum N

series ordinal

2

1 reference

31 July 2017

publication date

1 February 2001

1 reference

Clinics in geriatric medicine

31 July 2017

published in

1 reference

31 July 2017

volume

17

1 reference

31 July 2017

issue

1

1 reference

31 July 2017

page(s)

189-202, ix

1 reference

Surgical management of patients on warfarin sodium

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970114-2

7 January 2021

Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970114-2

7 January 2021

Management of Thrombo-Embolism after Aortic Valve Replacement with the Björk-Shiley Tilting Disc Valve: Medicamental Prevention with Dicumarol in Comparison with Dipyridamole—Acetylsalicylic Acid. Surgical Treatment of Prosthetic Thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970114-2

7 January 2021

Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970114-2

7 January 2021

The clinical course of pulmonary embolism

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970114-2

7 January 2021

Incidence of systemic embolism before and after mitral valvotomy

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970114-2

7 January 2021

Physician preferences for perioperative anticoagulation in patients with a mechanical heart valve who are undergoing elective noncardiac surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970114-2

7 January 2021

Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study).

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970114-2

7 January 2021

Hypercoagulable state and thromboembolism following warfarin withdrawal in post-myocardial-infarction patients

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970114-2

7 January 2021

Comparison of 5-mg and 10-mg loading doses in initiation of warfarin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970114-2

7 January 2021

Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970114-2

7 January 2021

Predictors of thromboembolism in atrial fibrillation: I. Clinical features of patients at risk. The Stroke Prevention in Atrial Fibrillation Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970114-2

7 January 2021

High risk of thromboemboli early after bioprosthetic cardiac valve replacement

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970114-2

7 January 2021

Clinical problem-solving: diagnosing spousal abuse

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970114-2

7 January 2021

Warfarin Sodium versus Low-Dose Heparin in the Long-Term Treatment of Venous Thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970114-2

7 January 2021

Clinical durability of the pericardial xenograft valve: ten years experience with mitral replacement

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970114-2

7 January 2021

Management of anticoagulation before and after elective surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970114-2

7 January 2021

Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970114-2

7 January 2021

Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970114-2

7 January 2021

Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970114-2

7 January 2021

Population pharmacokinetics of racemic warfarin in adult patients

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970114-2

7 January 2021

Epidural analgesia and anticoagulant therapy. Experience with one thousand cases of continuous epidurals.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970114-2

7 January 2021

Oral anticoagulation treatment in the elderly: a nested, prospective, case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970114-2

7 January 2021

Warfarin withdrawal. Pharmacokinetic-pharmacodynamic considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970114-2

7 January 2021

Prophylactic Greenfield filters: acute complications and long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970114-2

7 January 2021

Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970114-2

7 January 2021

Prothrombin time ratio and other factors associated with bleeding in patients treated with warfarin

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970114-2

7 January 2021

Prevalence of cardiovascular disease and diabetes mellitus in residents of Rochester, Minnesota

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970114-2

7 January 2021

EVIDENCE FOR "REBOUND" HYPERCOAGULABILITY AFTER STOPPING ANTICOAGULANTS

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970114-2

7 January 2021

Prevention of postsurgical bleeding in oral surgery using tranexamic acid without dose modification of oral anticoagulants.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970114-2

7 January 2021

Dental extractions in patients with bleeding disorders. The use of fibrin glue

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970114-2

7 January 2021

Protein C response to induction and withdrawal of oral anticoagulant treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970114-2

7 January 2021

The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970114-2

7 January 2021

A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970114-2

7 January 2021

Hemostatic effect of tranexamic acid mouthwash in anticoagulant-treated patients undergoing oral surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970114-2

7 January 2021

SPINAL EPIDURAL HEMATOMA DURING ANTICOAGULANT THERAPY. REPORT OF TWO CASES

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970114-2

7 January 2021

Transesophageal echocardiography to assess embolic risk in patients with atrial fibrillation. ELAT Study Group. Embolism in Left Atrial Thrombi.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970114-2

7 January 2021

SYSTEMIC EMBOLISM AND ANTICOAGULANT PROPHYLAXIS IN RHEUMATIC HEART DISEASE.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970114-2

7 January 2021

Oral anticoagulants controlled by the British comparative thromboplastin versus low-dose heparin in prophylaxis of deep vein thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970114-2

7 January 2021

Management of anticoagulants in a patient requiring major surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970114-2

7 January 2021

Discontinuing anticoagulant therapy in surgical patients with cardiac valve prostheses. Observations in 180 operations

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970114-2

7 January 2021

Peridural anaesthesia and anti-coagulant therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970114-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970114-2

1 reference

7 January 2021

Prospective evaluation of anticoagulant reversal with oral vitamin K1 while continuing warfarin therapy unchanged.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970114-2

7 January 2021

Temporary discontinuation of warfarin therapy: changes in the international normalized ratio

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970114-2

7 January 2021

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970114-2

7 January 2021

10.1016/S0749-0690(05)70114-2

Identifiers

DOI

1 reference

31 July 2017

1 reference